Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2025-12-25 @ 8:50 PM
Study NCT ID:
NCT03026556
Status:
COMPLETED
Last Update Posted:
2019-06-03
First Post:
2017-01-18
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
The Comparative Safety and Effectiveness of Dabigatran, Versus Rivaroxaban, and Apixaban Utilized in the Department of Defense Non-Valvular Atrial Fibrillation Patient Population: A Retrospective Database Analysis
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-12-29
Start Date Type:
ACTUAL
Primary Completion Date:
2017-08-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-08-23
Completion Date Type:
ACTUAL
First Submit Date:
2017-01-18
First Submit QC Date:
None
Study First Post Date:
2017-01-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-08-20
Results First Submit QC Date:
None
Results First Post Date:
2019-06-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-02-20
Last Update Post Date:
2019-06-03
Last Update Post Date Type:
ACTUAL